Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Summary of recent advances It is well accepted that bacterial pathogens growing in a biofilm are recalcitrant to the action of most antibiotics and are resistant to the innate immune system. New treatment modalities are greatly warranted to effectively eradicate these infections. However, bacteria growing in a biofilm are metabolically unique in comparison to bacteria grown in a planktonic state. Unfortunately, most antibiotics have been developed to inhibit growth of bacteria growing in a planktonic mode of growth. This review focuses on the metabolism and physiology of biofilm growth with special emphasis on the staphylococci. Future treatment options should include targeting unique metabolic niches found within bacterial biofilms in addition to enzymes or compounds that inhibit biofilm accumulation molecules and/or interact with quorum sensing and intercellular bacterial communication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982 · cited 1×
“In addition, recent data have demonstrated that multiple classes of bactericidal antibiotics stimulate the production of hydroxyl radicals through Fenton chemistry thus accelerating bacterial cell death [1].”
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
Shak, S., Capon, D. J., Hellmiss, R., Marsters, S. A., & Baker, C. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9188 · Cited by 707
Izano, E. A., Amarante, M. A., Kher, W. B., & Kaplan, J. B. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02073-07 · Cited by 553 · cited 2×
“aureus biofilms are DNase I susceptible and Dispersin B resistant [60].”
SarA and not σB is essential for biofilm development by Staphylococcus aureus
Valle, J., Toledo‐Arana, A., Berasain, C., Ghigo, J., Amorena, B., Penadés, J. R., & Lasa, I. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03493.x · Cited by 442
Therapeutic Potential of Biofilm-Dispersing Enzymes
Kaplan, J. B. (2009) · The International Journal of Artificial Organs · doi:10.1177/039139880903200903 · Cited by 217
Ganeshnarayan, K., Shah, S. M., Libera, M. R., Santostefano, A., & Kaplan, J. B. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01900-08 · Cited by 51 · cited 1×
“epidermidis, PIA is essential for the development of large (50 mm) three-dimensional towers, resistance to fluid shear stress, and resistance to biocides and neutrophildependent killing [10,14,15].”
Cited by
Kostakioti, M., Hadjifrangiskou, M., & Hultgren, S. J. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010306 · Cited by 999
Toxins-antitoxins: diversity, evolution and function
Hayes, F., & Van Melderen, L. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.600437 · Cited by 277
Staphylococcal biofilm disassembly
Boles, B. R., & Horswill, A. R. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.06.004 · Cited by 276
Qin, L., Yang, S., Zhao, C., Yang, J., Li, F., Xu, Z., Yang, Y., Zhou, H., Li, K., Xiong, C., et al. (2024) · Bone Research · doi:10.1038/s41413-024-00332-w · Cited by 190
Kirby, A. E., Garner, K., & Levin, B. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06480-11 · Cited by 72
Bacteriophage–host interaction: from splendid isolation into a messy reality
Brüssow, H. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.04.007 · Cited by 49
“estimated that 80% of all human infections are biofilmrelated, prominent examples are catheter-associated infections, cystic fibrosis-associated lung infections, or endocarditis [23].”
Background
Metadata
- Authors
- Fey, P. D.
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 13
- Issue
- 5
- Pages
- 610-615
- ISSN
- 1369-5274 (ISSN-L)
- OpenAlex
- W1965397129
- Cited by
- 106
- References
- 7
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.